All Releases

May 7, 2008
Enzon Reports Strong First Quarter 2008 Results 16.0 KB

May 7, 2008
Enzon Pharmaceuticals, Inc. Announces Plan to Spin-off Biotechnology Business 8.3 KB

Apr 30, 2008
Enzon to Release First Quarter 2008 Earnings on Wednesday, May 7, 2008 5.4 KB

Apr 23, 2008
Cimzia(R), Utilizing Enzon's Pegylation Technology, Approved in the U.S. 7.4 KB

Apr 9, 2008
Enzon to Present Preclinical Data On HIF-1alpha antagonist at AACR 5.0 KB

Mar 17, 2008
Enzon's PEG-SN38 Featured in Clinical Cancer Research 8.0 KB

Feb 14, 2008
Enzon Reports Significant Progress on the Reduction of Its Debt 5.6 KB

Feb 14, 2008
Enzon Reports Solid 2007 Results 25.5 KB

Feb 12, 2008
Enzon Pharmaceuticals to Add New Independent Director to Board 5.9 KB

Feb 8, 2008
Enzon to Release Earnings on Thursday, February 14, 2008; Conference Call and Webcast to Follow 4.8 KB

Dec 10, 2007
Enzon Presents New PEG-SN38 Preclinical Data at ASH 7.3 KB

Nov 29, 2007
Enzon to Present at BMO Capital Markets Focus on Healthcare Conference

Oct 30, 2007
Enzon Initiates Second Phase 1 Study of Its HIF-1 Alpha Antagonist

Oct 30, 2007
Enzon Provides New Data on Customized Linker Technology

Oct 30, 2007
Enzon Reports Third Quarter 2007 Results

Oct 26, 2007
Enzon to Webcast Live from Investor Day in NYC

Sep 26, 2007
Enzon Pharmaceuticals to Sponsor Investor Day in NYC

Sep 6, 2007
Enzon to Present at Bear Stearns 20th Annual Healthcare Conference

Aug 20, 2007
Enzon to Eliminate Its Remaining 2008 Convertible Debt

Aug 2, 2007
Enzon Reports Second Quarter 2007 Results

Showing 1-20 of 224

Page: 1 2 3 ... 12

Next 20